Anti-Cancer Agents in Medicinal Chemistry
ISSN 1871-5206 (Print)
ISSN 1875-5992 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Retracted articles
Archives
Contact
Editorial board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Categories
Keywords
Akt
Angiogenesis
Anticancer
Anticancer activity
Apoptosis
Breast cancer
Cancer
anticancer
apoptosis
autophagy
breast cancer
cancer
chemotherapy
cytotoxicity
glioblastoma
immunotherapy
metastasis
molecular docking
oxidative stress
proliferation
prostate cancer
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Categories
Keywords
Akt
Angiogenesis
Anticancer
Anticancer activity
Apoptosis
Breast cancer
Cancer
anticancer
apoptosis
autophagy
breast cancer
cancer
chemotherapy
cytotoxicity
glioblastoma
immunotherapy
metastasis
molecular docking
oxidative stress
proliferation
prostate cancer
Home
>
Search
>
Author Details
Author Details
De, Surya
Issue
Section
Title
File
Vol 23, No 12 (2023)
Oncology
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis
(Eng)
Vol 23, No 14 (2023)
Oncology
Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer
(Eng)
Vol 25, No 6 (2025)
Oncology
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer
(Eng)
TOP